Spectrum Brands Holdings faces structural concerns despite operational strengths, with sluggish revenue growth and declining sales in key divisions raising red flags for investors. Tariff impacts and ...

Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon (formerly eflapegrastim), a long-acting G-CSF for treating chemotherapy-induced neutropenia (CIN). The FDA's ...

“You always have to make certain market assumptions,” Harbinger Capital Investments founder Phil Falcone said at Delivering Alpha in September 2011. “My assumptions are that mosquitoes will still bite ...

Scientists report the first ever measurement on the optical spectrum of an antimatter atom. This achievement features technological developments that open up a completely new era in high-precision ...